1 |
Simeon-Dubach D, Watson P. Biobanking 3.0: evidence based and customer focused biobanking. Clinical biochemistry. 2014;47(4):300-308.
DOI
|
2 |
http://ukdataservice.ac.uk/
|
3 |
https://biolincc.nhlbi.nih.gov/static/studies/teaching/framdoc.pdf.
|
4 |
http://kbn.cdc.go.kr.
|
5 |
Korea Health Industry development institute. 2014 Health Industry White Paper. 2015. p.448-450. (Korean)
|
6 |
Korea Institute of Oriental Medicine. 2014 Year book of traditional Korean medicine. 2015. p116-117. (Korean)
|
7 |
Korea Centers for Disease Control and Prevention. Development of system for performance analysis utilizing the National Biobank of Korea(NBK)'s bioresource. 2015. (Korean)
|
8 |
Jin HJ, Baek Y, Kim HS, Ryu J, Lee S. Constitutional multicenter bank linked to Sasang constitutional phenotypic data. BMC complementary and alternative medicine. 2015;15:46.
DOI
|
9 |
Baek YH, Jin HJ, Kim HS, Jang ES, Lee SW. An Overview on the Construction of Korea Constitutional Multicenter Bank for Sasang Constitutional Medicine. J of Sasang Constitutional Medicine. 2012;24(2):47-53. (Korean)
DOI
|
10 |
Lee HY, Lee PY. Introduction to sample survey. Kyowoo. 2002. p133. (Korean)
|
11 |
Korea Centers for Disease Control and Prevention. 2016-2020 The 3rd Korea Biobank Project Plan. 2016. (Korean)
|
12 |
Ko SB et al. Investigating unmet research needs based on data of the Korean Genome and Epidemiology Study. 2015. (Korean)
|
13 |
Kang B, Park J, Cho S, Lee M, Kim N, Min H, Han B. Current status, challenges, policies, and bioethics of biobanks. Genomics & informatics. 2013;11(4):211-217.
DOI
|
14 |
Rogers J, Carolin T, Vaught J, & Compton C. Biobankonomics: a taxonomy for evaluating the economic benefits of standardized centralized human biobanking for translational research. Journal of the National Cancer Institute Monographs. 2011;42:32-38.
|
15 |
Biobanking for medicine: technology, industry and market 2014-2024. 2014.
|